Notice2024-09659
Foreign-Trade Zone (FTZ) 21, Notification of Proposed Production Activity; Patheon API Inc.; (Pharmaceutical Products); Florence, South Carolina
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
May 3, 2024
Issuing agencies
Commerce DepartmentForeign-Trade Zones Board
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 87 (Friday, May 3, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 87 (Friday, May 3, 2024)]
[Notices]
[Page 36753]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-09659]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board
[B-17-2024]
Foreign-Trade Zone (FTZ) 21, Notification of Proposed Production
Activity; Patheon API Inc.; (Pharmaceutical Products); Florence, South
Carolina
Patheon API Inc. submitted a notification of proposed production
activity to the FTZ Board (the Board) for its facilities in Florence,
South Carolina, within Subzone 21J. The notification conforming to the
requirements of the Board's regulations (15 CFR 400.22) was received on
April 26, 2024.
Pursuant to 15 CFR 400.14(b), FTZ production activity would be
limited to the specific foreign-status material(s)/component(s) and
specific finished product(s) described in the submitted notification
(summarized below) and subsequently authorized by the Board. The
benefits that may stem from conducting production activity under FTZ
procedures are explained in the background section of the Board's
website--accessible via <a href="http://www.trade.gov/ftz">www.trade.gov/ftz</a>.
The proposed finished products include: oseltamivir phosphate--
active pharmaceutical ingredient (API); benserazide hydrochloric acid
(Parkinson's Disease finished drug); AMG 510 API; capecitabine API;
MSBA-30K (methyl succinimidyl butanoic acid 30 kilodalton) API; and,
PEG2-NHS (PEGinterferon with N-hyroxysuccinate) finished drug (duty
rate ranges from duty-free to 6.5%).
The proposed foreign-status materials and components include:
resorcinol; ethyl alcohol (specifically denatured alcohol); ethyl
acetate; hydrogen; hydrochloric acid; silica gel pack; sodium hydroxide
solid and in solution; sodium hydroxide; copper II sulfate
pentahydrate; palladium (catalyst); N-heptane; methylene chloride,
unpreserved; methanol; benzaldehyde; pyrogallolaldehyde; glacial acetic
acid; N-pentylchloroformate; 2-Bromo-5-hydroxybenzoic acid; DL-serine
hydrazide hydrochloride; pyridine, 99.5%; aminofuranoside; capecitabine
API; sodium bicarbonate; fiber drum (cardboard); drum (high density
polyethylene); drum (steel); and, drum jet ring (steel) (duty rate
ranges from duty-free to 5.8%). The request indicates that certain
materials/components are subject to duties under section 301 of the
Trade Act of 1974 (section 301), depending on the country of origin.
The applicable section 301 decisions require subject merchandise to be
admitted to FTZs in privileged foreign status (19 CFR 146.41).
Public comment is invited from interested parties. Submissions
shall be addressed to the Board's Executive Secretary and sent to:
<a href="/cdn-cgi/l/email-protection#1573616f5561677471703b727a63"><span class="__cf_email__" data-cfemail="4422303e0430362520216a232b32">[email protected]</span></a>. The closing period for their receipt is June 12, 2024.
A copy of the notification will be available for public inspection
in the ``Online FTZ Information System'' section of the Board's
website.
For further information, contact Diane Finver at
<a href="/cdn-cgi/l/email-protection#17537e76797239517e7961726557636576737239707861"><span class="__cf_email__" data-cfemail="3c78555d5259127a55524a594e7c484e5d5859125b534a">[email protected]</span></a>.
Dated: April 30, 2024.
Elizabeth Whiteman,
Executive Secretary.
[FR Doc. 2024-09659 Filed 5-2-24; 8:45 am]
BILLING CODE 3510-DS-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on May 3, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.